Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaniv Sherer

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Harefuah|September 9, 2005
[Accelerated atherosclerosis in rheumatoid arthritis]Daniel Shepshelovich, Yaniv Sherer, Yehuda Shoenfeld
Clinical Reviews in Allergy & Immunology|January 4, 2008
Cutting edge issues in autoimmunityYaniv Sherer, Torsten Matthias, Yehuda Shoenfeld
Harefuah|October 13, 2005
[Dermatological manifestations in the antiphospholipid syndrome]Gilad Twig, Yaniv Sherer, Yehuda Shoenfeld
Autoimmunity|December 18, 2009
Atherosclerosis in systemic lupus erythematosusYaniv Sherer, Hasia Zinger, Yehuda Shoenfeld
Expert Opinion on Drug Safety|August 9, 2003
IVIG in autoimmunity and cancer--efficacy versus safetyYaniv Sherer, Yair Levy, Yehuda Shoenfeld
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Antiphospholipid syndrome (APS): where does it come from?Yaniv Sherer, Miri Blank, Yehuda Shoenfeld
Trends in Immunology|June 20, 2002
The expanding world of autoimmunityYehuda Shoenfeld, Yaniv Sherer, Joachim R Kalden
Nature Clinical Practice. Rheumatology|November 27, 2007
Tobacco smoking and autoimmune rheumatic diseasesMichal Harel-Meir, Yaniv Sherer, Yehuda Shoenfeld
Autoimmunity Reviews|August 19, 2008
Pemphigus and infectious agentsLior Sagi, Yaniv Sherer, Henri Trau, et al.
Autoimmunity Reviews|February 24, 2007
Safety of intravenous immunoglobulin (IVIG) therapyUriel Katz, Anat Achiron, Yaniv Sherer, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Harefuah|September 9, 2005
[Accelerated atherosclerosis in rheumatoid arthritis]Daniel Shepshelovich, Yaniv Sherer, Yehuda Shoenfeld
Clinical Reviews in Allergy & Immunology|January 4, 2008
Cutting edge issues in autoimmunityYaniv Sherer, Torsten Matthias, Yehuda Shoenfeld
Harefuah|October 13, 2005
[Dermatological manifestations in the antiphospholipid syndrome]Gilad Twig, Yaniv Sherer, Yehuda Shoenfeld
Autoimmunity|December 18, 2009
Atherosclerosis in systemic lupus erythematosusYaniv Sherer, Hasia Zinger, Yehuda Shoenfeld
Expert Opinion on Drug Safety|August 9, 2003
IVIG in autoimmunity and cancer--efficacy versus safetyYaniv Sherer, Yair Levy, Yehuda Shoenfeld
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Antiphospholipid syndrome (APS): where does it come from?Yaniv Sherer, Miri Blank, Yehuda Shoenfeld
Trends in Immunology|June 20, 2002
The expanding world of autoimmunityYehuda Shoenfeld, Yaniv Sherer, Joachim R Kalden
Nature Clinical Practice. Rheumatology|November 27, 2007
Tobacco smoking and autoimmune rheumatic diseasesMichal Harel-Meir, Yaniv Sherer, Yehuda Shoenfeld
Autoimmunity Reviews|August 19, 2008
Pemphigus and infectious agentsLior Sagi, Yaniv Sherer, Henri Trau, et al.
Autoimmunity Reviews|February 24, 2007
Safety of intravenous immunoglobulin (IVIG) therapyUriel Katz, Anat Achiron, Yaniv Sherer, et al.
Pageof 7